Community Liver Alliance National Liver Gathering

September 25, 2025 to September 27, 2025

Learning Objectives

At the conclusion of this activity, participants should be able to:

Apply current clinical guidelines and emerging evidence to the diagnosis and management of a broad range of liver diseases, including MASLD/MASH, autoimmune liver diseases, liver cancer, and rare conditions.
Implement effective screening, risk stratification, and early intervention strategies to improve outcomes for patients at risk of or living with liver disease.
Integrate patient and caregiver perspectives into individualized care plans to enhance engagement, adherence, and quality of life.
Collaborate effectively within interprofessional teams to deliver coordinated, comprehensive liver care across the continuum—from prevention to transplant. Recognize and address health disparities and social determinants of health that impact liver disease prevalence, diagnosis, treatment, and outcomes.
Engage in advocacy and policy efforts that promote liver health, equitable access to care, and support for individuals affected by liver disease.

Course summary
Available credit: 
  • 21.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 21.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 21.00 ASWB
  • 21.00 Attendance
Course opens: 
07/22/2025
Course expires: 
12/31/2025
Event starts: 
09/25/2025 - 7:00am EDT
Event ends: 
09/27/2025 - 5:00pm EDT
Add to calendar: 
Sheraton Station Square
Pittsburgh, PA
United States

Faculty Disclosure:

All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated.

Michael Babich- Speakers’ Bureau- Ipsen, Intercept, Madrigal
Kimberly Martinez- Consultant- Madrigal, Eli Lilly, Rare Patient Voice
Andrew Talal- Grant/Research support: Gilead, Abbott Laboratories, Novo Nordisk, AstraZeneca, Salix.  Committee/Advisor- Gilead, AbbVie, Novo Nordisk, Madrigal. Privately held stock: Empath Medical Innovations
Gina Madison- Grant/Research support- Madrigal; Regeneron
Jenn Jones- Patient Advisory Boards :Boehringer Ingelheim, Glaxo Smith Kline Madrigal—Patient Advisor
D. Lansing Taylor- Stock Options- PredxBio-spatial proteomics company. Grant/Research Support: National Institutes of Health
James E Squires- Consultant: Ipesn, Mirum
Maya Balakrishnan- Grant/Research support: Madrigal Pharmaceuticals, Boehringer Ingelheim, Novo Nordisk. Advisory Board: Madrigal Pharmaceutical
Satdarshan Monga-Consultant: UbiquiTx, Vicero Inc, Mermaid Bio, AntlerA. Grant/Research Support: Alnylam Pharmaceuticals, Fog Pharmaceuticals, Revolution Medicines. Publicly Held Stock: AntlerA (Purchased by Roche). Privately Held Stock: Mermaid Bio
Akshata Moghe- Speaker (Recordati Rare Diseases, Inc.). Advisor/Consultant:Recordati Rare Diseases, Inc., Alnylam Pharma
Anahita Rabiee- Grant/Research support: Grifols
Anthony Martinez-CE Speakers’ Bureau: Abbvie; Gilead; Madrigal; Braeburn; Ipsen; Cepheid. Consultant: Abbvie; Gilead; Madrigal; Braeburn; Ipsen; Cepheid. Grant/Research Support: Cepheid
Michael Betel- acted as speaker or moderator for Medscape Education, Novo Nordisk, Boehringer and served as an advisory board member for PPD, Worldwide Clinical Studies, Regeneron, WebMD, Sonic Incytes and Madrigal. Grant/Research Support: Fatty Liver Alliance has received unrestricted funding from Madrigal Pharmaceuticals, Novo Nordisk, Regeneron, Perspectum, Aegle Medical, Medscape, Echosens,  Siemens-Healthineers, Boehringer and Mind-Ray.
Simon Horslen-Consultant: Ipsen/Albireo. Grant/Research Support: Mirum. IPSEN (Hepatic safety monitoring board member for several studies)
Teresas Davidson- CE Speakers’ Bureau: Madrigal
Matthew Barnes- CE Speakers’ Bureau: AbbVie
Rachel Shuster- Consultant: Brand Holdings, LLC: Overdrive
Tuesdae Stainbrook- CE Speakers’ Bureau: Gilead, AbbVie, Paratek. Consultant: Gilead, AbbVie. Grant/Research Support: CDA
Betsy Villiotti- Grant/Research Support: Madrigal, Eisai, Regeneron, 89Bio, Akero
Christopher Frates- Publicly held stock: Madrigal
Kerry Sivia- Consultant: Madrigal Pharmaceuticals
Megan Murphy- Employee of GSK
Jaideep Behari-Grant/Research Support: AstraZeneca, Gilead, Madrigal. Institutional research contracts with: Madrigal, Inventiva,Rhythm, Akero
Olivier Viel- Other: Merck employee

No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 
 


In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and Community Liver Alliance. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 21 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 21 contact hours.

Social Work (ASWB)
As a Jointly Accredited Organization, the University of Pittsburgh is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 21 general continuing education credits.

Other Healthcare Professionals: Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 21.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 21.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 21.00 ASWB
  • 21.00 Attendance

Thank you to our exhibitors:

Astra Zeneca
Gilead
Ipsen
Mallinckrodt Pharma
Takeda Pharmaceuticals

Please login or register to take this course.